QBU-30613-30833
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 111 / NY
- Registered
- 2021-07-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-12
Registered in v-safe
-
2021-07-12
Dose 1 — Pfizer-BioNTech
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-15
- 2021-07-16
- 2021-07-17
- 2021-07-18
- 2021-07-19
- 2021-07-26
- 2021-08-02
-
2021-08-06
Dose 2 — Pfizer-BioNTech
- 2021-08-09
- 2021-08-10
- 2021-08-11
- 2021-08-12
- 2021-08-13
- 2021-08-20
- 2021-08-27
- 2021-09-03
- 2021-09-10
- 2021-09-17
- 2021-11-05
-
2022-02-06
Survey response — 6 months, dose 2MedDRA: Headache, Oropharyngeal pain, Pain, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: Tested positive for Covid after experiencing aches, headaches, sore throat.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-12 | Pfizer-BioNTech | No |
| 2 | 2021-08-06 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 2
Symptoms: Tested positive for Covid after experiencing aches, headaches, sore throat.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release